Belén Garijo Says Sanofi Has “No Target Number” for Pipeline Cuts as Big Pharma’s Q2 Masks a Looming Cliff — BigGo Finance
Nine of the world’s 25 largest drugmakers grew revenue by double digits in the second quarter of 2026.…
Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
With all the fretting from the pharmaceutical industry about competition from China, patent protection losses, price reduction initiatives…
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer
For Immediate Release Chicago, IL – March 3, 2026 – Today, Zacks Equity Research discusses Eli Lilly LLY,…